George Ng Email Address

Chief Executive Officer and Board Director

Focusing on the development of oncologic agents for the treatment for cancers

George Ng, a partner at PENG Life Science Ventures (PENG LSV), is a seasoned life sciences industry executive. He has founded and/or led multiple companies, including Scilex Pharmaceuticals, Inc., where he was Co-Founder and President, and led the company through development, clinical trials, NDA submission, FDA approval, $140 million financing, commercial launch of the company’s first FDA-approved drug product, and company sale/merger. Mr. Ng has also held various other senior management positions, including Board Director, Managing Director, Chief Business Officer, Chief Administrative Officer, Corporate Secretary, Chief Legal Officer, General Counsel, Chief Compliance Officer and Chief Intellectual Property Counsel, with publicly-traded and private, global biotechnology and pharmaceutical companies, including Sorrento Therapeutics, Inc. (NASDAQ: SRNE), BioDelivery Sciences International, Inc. (NASDAQ: BDSI), Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) and Alpharma, Inc. (now, a part of Pfizer Inc.). In these roles, Mr. Ng helped lead the development and commercialization efforts and launches of multiple pharmaceutical drug products. Previously, in private practice, Mr. Ng was a partner in two AMLAW 200 law firms, where he had leadership roles, including establishing the life sciences practice group for one firm and heading it as the national co-chair. Additionally, Mr. Ng is a current member of the Board of Directors or Advisor for multiple companies, including Iacta Pharmaceuticals, Inc., Inflammatory Response Research, Inc. (IRR), Morphogenesis, Inc. and Calidi Biotherapeutics, Inc.